Close

Articles Posted in Product Liability

Updated:

J&J Risperdal Gynecomastia Verdicts

Johnson & Johnson, (J&J) the world’s largest pharmaceutical and medical device maker recently received a one, two punch over its antipsychotic blockbuster drug, Risperdal. The drug manufacturer lost the first trial in state court in Philadelphia over allegations that Risperdal causes gynecomastia or abnormal breast growth in boys and young…

Updated:

Xarelto Wrongful Death Lawsuits Ramping Up

According to court documents and a review of the inventory of filed lawsuits against the makers of Xarelto, the litigation appears to be gathering steam and increasing in breadth and depth. In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) granted consolidated pretrial proceedings for all federal Xarelto…

Updated:

J&J to Settle More Defective DePuy ASR Hip Lawsuits

DePuy ASR metal on metal hip replacements continue to fail prematurely and require painful and risky revision surgery. Johnson and Johnson, the world’s largest pharmaceutical and medical device maker and its subsidiary DePuy, recently agreed to extend the settlement of its notorious line of failed metal on metal hips, to…

Updated:

Actos Bladder Cancer Cases Heading to Settlement

There is a big push underway to try and resolve all of the Actos bladder cancer lawsuits. The U.S. District Judge presiding over all federal Actos bladder cancer lawsuits will require the parties to discuss settlements in advance of a bellwether trial scheduled in 2016. In that trial at least…

Updated:

Actos Bladder Cancer Claims Continue

Recently earlier this month, seventeen plaintiffs filed an Actos bladder cancer lawsuit against manufacturer Takeda Pharmaceuticals, blaming that the use of the type 2 diabetes treatment led to the diagnosis of bladder cancer. Four of the plaintiffs had died from advanced bladder cancer. The other plaintiffs have experienced recurrences of…

Updated:

Zofran Cleft Lip, Cleft Palate, Heart Birth Defects

Zofran, is an anti-nausea medication that is commonly prescribed for morning sickness. However, recent medical studies have found pregnancy side effects that may increase the risk of severe and debilitating birth defects in children. GlaxoSmithKline Allegations Patients have blamed GlaxoSmithKline’s failure to adequately research their medication or warn about the…

Updated:

Bard Avaulta TransVaginal Mesh Settlement in the Works

After a hard fought, protracted and bitter fight that has consumed the last 5 years, the Bard Avaulta transvaginal mesh litigation is finally heading for a global settlement. U.S. District Judge, John Goodwin, who presiding over all federal vaginal mesh lawsuits has appointed a Special Master to forge settlement talks…

Updated:

Philadelphia Actos Trial Results in $2.3 M Verdict

A Philadelphia state court jury earlier this week, concluded that Actos caused bladder cancer. Takeda Pharmaceutical Co. the manufacturer of Actos, received another setback in the conclusion of yesterday’s trial, when the jury also determined that the company acted recklessly and found that punitive damages should be awarded. Takeda Pharmaceutical…

Updated:

Philadelphia $2M Actos Bladder Cancer Verdict Upheld

Judge Shelly Robins, from Pennsylvania has denied the appeal of a $2 million verdict awarded in October to a plaintiff who blamed Takeda Pharmaceuticals Inc.’s drug Actos was a significant contributor to her developing bladder cancer. In an order docketed on Friday, Philadelphia Court of Common Pleas Judge Shelly Robins…

Updated:

J&J Hammered Over Risperdal Male Breast Injuries

Currently underway in the State Court of Common Pleas in Philadelphia, there is a trial over the side effects of Risperdal, a popular antipsychotic medication. According to riveting court testimony, Johnson & Johnson (J&J), knew as early as 2001 that the medication caused boys to grow breasts. This testimony was…

Contact Us
Start Chat